Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-Order our 2017 Brochure

Our 2016 senior faculty included:

John Whyte
John Whyte

FDA

Director of Professional Affairs and Stakeholder Engagement

Craig Lipset
Craig Lipset

Pfizer

Head of clinical innovation

Alan Wright
Alan Wright

Roche

Chief Medical Officer

Klaus Dugi
Klaus Dugi

Boehringer Ingelheim

Managing director & fmr Chief Medical Officer

Barbara Tardiff
Barbara Tardiff

Pfizer

Vice President, Global Head Clinical Informatics and Innovation

Anthony G. Johnson
Anthony G. Johnson

AstraZeneca

Vice President, Head, Early Clinical Development

Mark Wiener
Mark Wiener

Temple University Health System

Chief Medical Information Officer

Julian Jenkins
Julian Jenkins

GSK

Vice President, Innovation Performance & Technology

Robert DiCicco
Robert DiCicco

GSK

Vice President, Clinical Innovation & Digital Platform Performance Unit

Henrik Finnern
Henrik Finnern

Boehringer Ingelheim

Chief Patient Officer

Joe Camardo
Joe Camardo

Celgene

Senior Vice President

Scott Lowry
Scott Lowry

HealthIDx

CEO

Join the FDA, top pharma CMOs, VPs, and 150+ clinical leaders, at the unmissable pharma-stakeholder summit.

eyeforpharma Data Quality and Technology in Clinical Trials is the most awaited global forum for leaders in clinical trials.

Roche, GSK, Pfizer, Amgen, AstraZeneca, Bayer, Novartis and others are joining their force to Revolutionize Clinical Trials. Join the movement at DTCT 2016 and:

  • The strategy and insight needed to outperform your clinical trials. CMOs, CEOs, SVPs, VPs from Roche, Pfizer, AstraZeneca, GSK, BI, Bayer, FDA and more will help ensure you keep ahead of the curve and enhance the productivity of your clinical studies.
  • Networking with the top industry innovators: This is clearly the only place to meet, collaborate and keep in touch with 150+ lead industry decision makers and be a part of the discussions that will reshape clinical trials.
  • Learning from your peers’ experience: Amgen, Gilead, FDA, GSK and others will share real life case studies and best practices - implement what you learn and be among the leaders!

Why Attend?

  • Hear from the top thought leaders and innovators: organizations that are joining us will gain exclusive insight before the rest of the industry
  • Most senior clinical meeting up-to-date: Before it appears on newspapers, be the first in the industry to hear about cutting edge strategic innovation and gain competitive advantage
  • Don’t be excluded from the industry consortium: on April 18-19, the companies present on board will design a clear plan to revolutionize clinical trials… Don’t be left behind…

Pre-Order our 2017 event brochure

Complete speaker line-up - Program for all tracks & sessions – Audience breakdown

These companies are committed to join their forces to revolutionize clinical trials at the eyeforpharma Data Quality & Technology in Clinical Trials

UCLA

Pre-Order our 2017 event brochure

Complete speaker line-up - Program for all tracks & sessions – Audience breakdown

Our Track-Record of Proven Success

83% call our sessions essential
94% say they'll return next year
97% rated the program very well done

What our Delegates are saying

Are you a patient?

Click here learn how to apply for an eyeforpharma patient scholarship